Exact FDA event identifier

Event 93096

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: October 18, 2023
Product types: Drug
Classifications: Class I
Statuses: Terminated
Recalling firm wording: VistaPharm LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by: VistaPharm, Inc. Largo, FL 33771 USA, NDC 66689-305-16

D-0047-2024

Recall number: D-0047-2024
Initiated: October 18, 2023
Classification: Class I
Status: Terminated
Recalling firm: VistaPharm LLC
Quantity: 180 bottles

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0

Microbial Contamination

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.

Code information

Lot#: 810300, Exp 10/2023

Distribution pattern

USA Nationwide